




Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline
NEW YORK, Jan. 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline.
Inspire Medical Systems, Inc. Inspire V Delays Lead to Securities Class Action – Contact BFA Law before January 5 Legal Deadline
NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline.
Important Inspire Medical Systems, Inc. Securities Fraud Class Action Deadline is Approaching for Investors – Contact BFA Law before January 5
NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline.
Geschäftstreiber: Der Medizintechnikkonzern Înspire Medical Systems (INSP) hat sich auf Neurostimulatoren gegen obstruktive Schlafapnoe spezialisiert. Mit dem "Inspire Therapy- System" verfügt man über...
Inspire Medical Systems investors that lost money are notified to contact BFA Law before the January 5, 2026 securities fraud class action deadline.
Inspire Medical Systems stock soars after Medicare reimbursement boost
Investors need to pay close attention to Inspire Medical Systems stock based on the movements in the options market lately.
NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 5, 2026.
NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE:INSP) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at [email protected], or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE:INSP) securities during the period of August 6, 2024 through August 4, 2025, inclusive (“the Class Period”).
Geschäftstreiber: Der Medizintechnikkonzern Înspire Medical Systems (INSP) hat sich auf Neurostimulatoren gegen obstruktive Schlafapnoe spezialisiert. Mit dem "Inspire Therapy- System" verfügt man über...
SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”), have until January 5, 2026 to seek appointment as lead plaintiff of the Inspire Medical class action lawsuit. Captioned City of Pontiac Reestablished General Employees’ Retirement System v. Inspire Medical Systems, Inc., No. 25-cv-04247 (D. Minn.)...
Image source: The Motley Fool.DateMonday, November 3, 2025 at 5 p.m. ETCall participantsChairman and Chief Executive Officer — Timothy P. HerbertChief Financial Officer — Richard J. BuchholzVice President, Investor Relations — Ezgi YagciNeed a quote from a Motley Fool analyst? Email [email protected] Financial Officer Richard J. Buchholz noted, "We now expect our reported tax rate in 2025 to be 25% as state minimum taxes are higher than expected."Chief Financial Officer Richard J. Buchh...
Inspire (INSP) delivered earnings and revenue surprises of +353.33% and +1.61%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Geschäftstreiber: Der Medizintechnikkonzern Înspire Medical Systems (INSP) hat sich auf Neurostimulatoren gegen obstruktive Schlafapnoe spezialisiert. Mit dem "Inspire Therapy" verfügt man über das...
Inspire (INSP) delivered earnings and revenue surprises of +104.55% and +0.95%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Theres a strong case that healthcare is the most important sector in the stock market. These companies deliver innovative therapies and medical technologies that are often life-saving. Investors stand to benefit as healthcare leaders and emerging players address the needs of an aging global population and the rising prevalence of chronic diseases.Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Here are 10 und...
Investors need to pay close attention to INSP stock based on the movements in the options market lately.
Tim Herbert, Founder, Chairman, President and CEO of publicly traded Inspire Medical Systems, discusses the companys breakthrough technology that helps people suffering from obstructive sleep apnea, as well as the companys strong quarterly earnings amid headwinds facing the broader health care industry. Tim speaks with Tim Stenovec and Emily Graffeo on Bloomberg Businessweek Daily. (Source: Bloomberg)
Inspire (INSP) delivered earnings and revenue surprises of 143.48% and 3.20%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Inspire (INSP) delivered earnings and revenue surprises of 55.41% and 0.04%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024 Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024
Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.